Physician profile
Mohammad Omar Ramadan
NPI 1205157120
$207,122.67
in general payments reported to CMS, 2019-2025
29 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,012 · 2020: $274 · 2021: $256 · 2022: $5,286 · 2023: $26K · 2024: $111K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $127K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Travel and Lodging: $16K · Food and Beverage: $10K · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $126,923.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,750.00 |
| Travel and Lodging | $16,246.85 |
| Food and Beverage | $10,366.84 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $202,589.98 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Janssen Research & Development, LLC | $1,199.84 | 2019 | |
| Medtronic, INC. | $1,118.13 | 2021-2025 | Interstim, Signia, Onyx 18 |
| Coloplast Corp | $442.51 | 2019-2025 | Porges Coloplast |
| Boston Scientific Corporation | $335.59 | 2019-2025 | Ams 700, Lumenis Pulse 120h, Axonics |
| Procept Biorobotics Corporation | $254.17 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $218.36 | 2021-2023 | Axonics, Bulkamid |
| Genzyme Corporation | $138.72 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $101.42 | 2024-2025 | Adstiladrin |
| Corcept Therapeutics | $100.15 | 2024 | Korlym |
| Olympus America INC. | $90.83 | 2021-2025 | Itind System |
| Urogen Pharma, INC. | $76.45 | 2023-2025 | Jelmyto |
| Calyxo, INC. | $50.57 | 2025 | Cvac Aspiration System |
| Abbott Laboratories | $46.26 | 2019 | |
| Sumitomo Pharma America, INC. | $35.92 | 2023-2025 | Gemtesa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $32.44 | 2019 | |
| Uromedica, Incorporated | $32.12 | 2019 | |
| Csl Behring | $29.84 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.14 | 2025 | Livtencity |
| Laborie Medical Technologies Corp. | $28.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Progenics Pharmaceuticals, INC. | $25.99 | 2023 | Pylarify |
| Innovation Technologies INC | $24.01 | 2025 | Irrisept |
| Teleflex LLC | $21.88 | 2024 | Urolift |
| Pacira Pharmaceuticals Incorporated | $21.75 | 2025 | Exparel |
| Civco Medical Instruments | $17.97 | 2025 | |
| Neotract INC. | $16.57 | 2019 | |
| Astellas Pharma US INC | $15.82 | 2022 | |
| Ethicon US, LLC | $15.50 | 2025 | Stratafix, Vistaseal |
| Bard Access Systems, INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Ramadan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.